Task: Answer the multiple choice question.
Question: Which drug exhibits a 2.281% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) CCn1c(=O)n(CC)c2cc(S(=O)(=O)N3CCc4ccccc43)ccc21
(b) CCOC(=O)C1CCN(S(=O)(=O)c2ccc3[nH]c(=O)c(=O)[nH]c3c2)CC1
Answer: a. CCn1c(=O)n(CC)c2cc(S(=O)(=O)N3CCc4ccccc43)ccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCn1c(=O)n(CC)c2cc(S(=O)(=O)N3CCc4ccccc43)ccc21
CCn1c(=O)n(CC)c2cc(S(=O)(=O)N3CCc4ccccc43)ccc21
5-(2,3-dihydroindol-1-ylsulfonyl)-1,3-diethylbenzimidazol-2-one